Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HEROZ, Inc. ( (JP:4382) ) has provided an update.
HEROZ, Inc. has agreed to transfer 79,499 shares of its consolidated subsidiary StrategIT Co., Ltd. to GMO GlobalSign Holdings K.K., with completion targeted around April 30, 2026. StrategIT develops and operates the iPaaS-based SaaS integration solution “JOINT,” which connects data and systems between SaaS applications and business platforms.
HEROZ decided on the sale to accelerate StrategIT’s growth and enhance its corporate value by placing it within GMO GlobalSign HD’s internet infrastructure and DX-focused group, which includes electronic certification, digital seal, and cloud infrastructure businesses. The move is expected to let StrategIT better leverage its accumulated SaaS integration technologies and expertise for broader business development, while representing a strategic portfolio shift for HEROZ and potentially strengthening GMO GlobalSign HD’s digital transformation capabilities.
More about HEROZ, Inc.
HEROZ, Inc., listed on the TSE Standard, operates in the digital and AI-driven technology sector, developing and providing software services that support corporate digital transformation. Through its group companies, including StrategIT Co., Ltd. prior to this transaction, HEROZ has been involved in SaaS integration solutions that help businesses connect and optimize their various cloud and internal systems.
Average Trading Volume: 64,836
Technical Sentiment Signal: Sell
Current Market Cap: Yen13.28B
See more insights into 4382 stock on TipRanks’ Stock Analysis page.